Transient Inhibition of Translation Improves Cardiac Function After Ischemia/Reperfusion by Attenuating the Inflammatory Response
Christoph P. Hofmann(Heidelberg University), Mirko Völkers(Heidelberg University), Norbert Frey(Heidelberg University), Arica Beisaw(Helmholtz Association of German Research Centres), Verena Kamuf‐Schenk(Heidelberg University), Fereshteh S. Younesi(St. Michael's Hospital), Ellen Malovrh(Heidelberg University), Hugo A. Katus(Heidelberg University), Etienne Boileau(Heidelberg University), Johannes Fischer(Heidelberg University), Frank Stein(European Molecular Biology Organization), Florian Leuschner(Heidelberg University), Claudia Stroh(Heidelberg University), Ole M. Schwerdt(Heidelberg University), Mandy Rettel(European Molecular Biology Organization), Adrian Serafin(Heidelberg University), Clara Sandmann(Heidelberg University), Nikole J. Byrne(Medical University of Graz), Heiko Bugger(University of Freiburg), Zoe Löwenthal(Heidelberg University), Ingmar S. Meyer(Heidelberg University), Florian Sicklinger(Heidelberg University), Daniel Finke(Heidelberg University), Lonny Jürgensen(Heidelberg University), Tobias Jakobi(Heidelberg University)
Cited by 26
Related Papers
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2009|7.1k
2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease
|European Heart Journal|2020|1.8k
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial
|The Lancet|2020|1.2k
European Society of Cardiology: cardiovascular disease statistics 2021
|European Heart Journal|2021|1.1k
Myocardial infarction accelerates atherosclerosis
|Nature|2012|1.1k